Table 1 Clinical characteristics of patients
Characteristics | n = 127 (%) | %GCEP | p value |
|---|---|---|---|
Sex | 0.585a | ||
Male | 69 (54.3%) | 1.16% (0.36–1.83) | |
Female | 58 (45.6%) | 1.13% (0.47–1.72) | |
Age group | 0.69a | ||
Young adult | 8 (6.3%) | 1.28% (0.61–1.89) | |
Middle-aged adult | 67 (52.8%) | 1.08% (0.32–1.78) | |
Older adult | 52 (40.9%) | 1.19% (0.49–1.74) | |
AJCC stage | < 0.0001b | ||
0 | 1(8.0%) | 0.55% | |
I | 4 (3.0%) | 1.38% (0.54–1.92) | |
IIA | 16 (12.0%) | 0.60% (0.14–0.93) | |
IIB | 8 (6.0%) | 1.10% (0.24–1.98) | |
III | 14 (10.5%) | 0.82% (0.17–1.70) | |
Iva | 34 (25.6%) | 0.99% (0.35–1.69) | |
IVb | 50 (37.6%) | 1.52% (1.22–1.88) | |
cTNM stage | |||
T | 0.247b | ||
Tis | 1 (0.8%) | 0.55% | |
T1 | 13 (10.2%) | 1.01% (0.48–1.65) | |
T2 | 11 (8.7%) | 0.85% (0.19–1.60) | |
T3 | 25 (19.7%) | 1.53% (1.10–1.96) | |
T4a | 39 (30.7%) | 1.07% (0.33–1.72) | |
T4b | 38 (29.9%) | 1.15% (0.16–1.85) | |
N | 0.616a | ||
N0 | 14 (11%) | 1.35% (0.74–2.01) | |
N1 | 34 (26.8%) | 1.01% (0.30–1.77) | |
N2 | 44 (34.6%) | 1.18% (0.51–1.73) | |
N3 | 35 (27.6%) | 1.21% (0.39–1.82) | |
M | < 0.0001a | ||
M0 | 75 (59.1%) | 0.91% (0.24–1.62) | |
M1 | 52 (40.9%) | 1.52% (1.17–1.88) | |
Lauren’s classification | 0.187b | ||
Nonclassifiable | 7 (5.5%) | 0.78% (0.90–0.93) | |
Intestinal | 49 (38.6%) | 1.13% (0.34–1.78) | |
Diffuse | 68 (53.5%) | 1.21% (0.52–1.78) | |
Mixed | 3 (2.4%) | 1.22% (0.85–1.80) | |
Histological grade | 0.259a | ||
Nonclassifiable | 6 (4.7%) | 0.62% (0.90–1.43) | |
Poorly differentiated | 98 (77.2%) | 1.00% (0.51–2.21) | |
Moderately differentiated | 17 (13.4%) | 0.81% (0.34–1.93) | |
Well differentiated | 6 (4.7%) | 0.72% (0.34–1.74) | |
Borrmann’s classification | 0.516a | ||
Type 1 | 8 (6.3%) | 1.43% (0.65–1.98) | |
Type 2 | 8 (6.3%) | 1.35% (0.49–1.98) | |
Type 3 | 55 (43.3%) | 1.23% (0.53–1.79) | |
Type 4 | 41 (32.3%) | 1.06% (0.26–1.73) | |
Type 5 | 15 (11.8%) | 0.88% (0.45–1.71) |